| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10461412 | Neuroscience & Biobehavioral Reviews | 2013 | 6 Pages |
Abstract
⺠Anxiety disorders have a 1-year prevalence of 14% and affect over 69 million people in the EU. ⺠They are distressing, impairing and costly and represent a major public health issue. ⺠There is much scope for improved recognition and treatment of anxiety disorders. ⺠Uncertain causes of anxiety disorders hinder the development of refined treatments. ⺠There is a need for research in more widely representative patient groups.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
David S. Baldwin, Stefano Pallanti, Peter Zwanzger,